Zhaoting Yang

845 total citations
26 papers, 647 citations indexed

About

Zhaoting Yang is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Zhaoting Yang has authored 26 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Zhaoting Yang's work include Cancer Cells and Metastasis (18 papers), Hedgehog Signaling Pathway Studies (7 papers) and Epigenetics and DNA Methylation (5 papers). Zhaoting Yang is often cited by papers focused on Cancer Cells and Metastasis (18 papers), Hedgehog Signaling Pathway Studies (7 papers) and Epigenetics and DNA Methylation (5 papers). Zhaoting Yang collaborates with scholars based in China, South Korea and United Kingdom. Zhaoting Yang's co-authors include Yanhua Xuan, Yan Cui, Weidong Ni, Chengye Zhang, Wenbo Qi, Longyun Fang, Ying Feng, Nan Che, Longzhen Piao and So-Young Yeo and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and American Journal Of Pathology.

In The Last Decade

Zhaoting Yang

25 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhaoting Yang China 17 382 304 182 88 85 26 647
Neel I. Nissen Denmark 11 202 0.5× 280 0.9× 132 0.7× 89 1.0× 112 1.3× 18 600
Eva Andreuzzi Italy 14 377 1.0× 155 0.5× 160 0.9× 120 1.4× 130 1.5× 25 671
Xiang Hang China 7 486 1.3× 397 1.3× 180 1.0× 119 1.4× 36 0.4× 20 756
James Patrick Heiserman United States 7 286 0.7× 183 0.6× 131 0.7× 53 0.6× 55 0.6× 8 515
Biancastella Cereser United Kingdom 10 266 0.7× 275 0.9× 216 1.2× 45 0.5× 34 0.4× 16 583
Francesca Merchionne Italy 13 362 0.9× 251 0.8× 125 0.7× 84 1.0× 77 0.9× 21 670
Tanja Rothhammer Germany 10 638 1.7× 233 0.8× 209 1.1× 71 0.8× 81 1.0× 12 831
Stefano Marastoni Italy 9 302 0.8× 110 0.4× 113 0.6× 88 1.0× 98 1.2× 14 522
Natascha Cremers Germany 11 239 0.6× 290 1.0× 137 0.8× 92 1.0× 38 0.4× 12 516
Andreas Enns Germany 9 506 1.3× 289 1.0× 129 0.7× 137 1.6× 122 1.4× 9 889

Countries citing papers authored by Zhaoting Yang

Since Specialization
Citations

This map shows the geographic impact of Zhaoting Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaoting Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaoting Yang more than expected).

Fields of papers citing papers by Zhaoting Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaoting Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaoting Yang. The network helps show where Zhaoting Yang may publish in the future.

Co-authorship network of co-authors of Zhaoting Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaoting Yang. A scholar is included among the top collaborators of Zhaoting Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaoting Yang. Zhaoting Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yang, Zhaoting, et al.. (2022). SETD5 Regulates Glycolysis in Breast Cancer Stem-Like Cells and Fuels Tumor Growth. American Journal Of Pathology. 192(4). 712–721. 18 indexed citations
3.
Yang, Zhaoting, et al.. (2021). B7-H4 induces epithelial–mesenchymal transition and promotes colorectal cancer stemness. Pathology - Research and Practice. 218. 153323–153323. 14 indexed citations
4.
Che, Nan, Zhaoting Yang, Mengxuan Li, et al.. (2020). Suppression of LETM1 inhibits the proliferation and stemness of colorectal cancer cells through reactive oxygen species–induced autophagy. Journal of Cellular and Molecular Medicine. 25(4). 2110–2120. 19 indexed citations
5.
Zhang, Chengye, Zhaoting Yang, Tae‐Su Jang, et al.. (2020). 3D culture technologies of cancer stem cells: promising ex vivo tumor models. Journal of Tissue Engineering. 11. 2752662815–2752662815. 55 indexed citations
6.
Yang, Zhaoting, et al.. (2020). Tenascin-C predicts poor outcomes for patients with colorectal cancer and drives cancer stemness via Hedgehog signaling pathway. Cancer Cell International. 20(1). 122–122. 21 indexed citations
7.
Qi, Wenbo, Zhaoting Yang, Ying Feng, et al.. (2020). Gli1 regulates stemness characteristics in gastric adenocarcinoma. Diagnostic Pathology. 15(1). 60–60. 9 indexed citations
9.
Li, Haoyue, et al.. (2020). SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness. Experimental Cell Research. 389(1). 111861–111861. 16 indexed citations
10.
Piao, Longzhen, et al.. (2019). LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma. BMC Cancer. 19(1). 898–898. 16 indexed citations
11.
Yang, Zhaoting, et al.. (2019). LETM1 is a potential cancer stem-like cell marker and predicts poor prognosis in colorectal adenocarcinoma. Pathology - Research and Practice. 215(7). 152437–152437. 24 indexed citations
12.
Yang, Zhaoting, Chengye Zhang, Wenbo Qi, Yan Cui, & Yanhua Xuan. (2018). GLI1 promotes cancer stemness through intracellular signaling pathway PI3K/Akt/NFκB in colorectal adenocarcinoma. Experimental Cell Research. 373(1-2). 145–154. 53 indexed citations
13.
14.
Piao, Longzhen, et al.. (2018). B7H4 is associated with stemness and cancer progression in esophageal squamous cell carcinoma. Human Pathology. 80. 152–162. 26 indexed citations
15.
Yang, Zhaoting, et al.. (2018). Tenascin-C as a prognostic determinant of colorectal cancer through induction of epithelial-to-mesenchymal transition and proliferation. Experimental and Molecular Pathology. 105(2). 216–222. 33 indexed citations
16.
Yang, Zhaoting, et al.. (2018). Gli1, a potential cancer stem cell marker, is strongly associated with prognosis in prostate cancer.. PubMed. 11(10). 4957–4966. 14 indexed citations
17.
Liu, Lan, Zhaoting Yang, Weidong Ni, & Yanhua Xuan. (2018). ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma. Experimental and Molecular Pathology. 104(2). 134–139. 12 indexed citations
18.
Ni, Weidong, et al.. (2017). Gli1 is a potential cancer stem cell marker and predicts poor prognosis in ductal breast carcinoma. Human Pathology. 69. 38–45. 8 indexed citations
19.
Cui, Yan, et al.. (2017). Gli1 expression in cancer stem-like cells predicts poor prognosis in patients with lung squamous cell carcinoma. Experimental and Molecular Pathology. 102(2). 347–353. 20 indexed citations
20.
Yeo, So-Young, Keun‐Woo Lee, Yan Cui, et al.. (2017). Twist1 is highly expressed in cancer-associated fibroblasts of esophageal squamous cell carcinoma with a prognostic significance. Oncotarget. 8(39). 65265–65280. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026